||American Hotel Income Properties REIT LP Announces February 2018 U.S. Dollar Cash Distribution
American Hotel Income Properties REIT LP ("AHIP") (TSX: HOT.UN) (TSX: HOT.U) (TSX: HOT.DB.U) announced today a cash distribution of US$0.054 per limited partnership unit ("Unit") for the period of February 1, 2018 to February 28, 2018, which is equivalent to US$0.648 per Unit on an annualized basis. The distribution will be paid on March 15, 2018 to unitholders of record at the close of business on February 28, 2018.
The policy of AHIP is to pay cash distributions on or about the 15th day of each month to the unitholders of record on the last business day of the preceding month.
ABOUT AMERICAN HOTEL INCOME PROPERTIES REIT LP
American Hotel Income Properties REIT LP (TSX: HOT.UN) (TSX: HOT.U) (TSX: HOT.DB.U), or AHIP, is a limited partnership formed to invest in hotel real estate properties located substantially in the United States. AHIP currently has 115 hotels, and is actively engaged in growing its portfolio of premium branded, select-service hotels in larger secondary markets that have diverse and stable demand. AHIP hotels operate under brands affiliated with Marriott, Hilton, IHG, Wyndham and Choice Hotels through license agreements. The company's long-term objectives are to build on its proven track record of successful investment, deliver reliable and consistent U.S. dollar denominated distributions to unitholders, and generate value through the continued growth of its diversified hotel portfolio. More information is available at www.ahipreit.com.
For further information, please contact:
Director, Investor Relations
||02/18/2018 03:40:41 PM
||Standard Lithium Announces Closing of $21.6 million Bought Deal Private Placement of Units
Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSX-V:SLL) (OTCQX:STLHF) (FRA:S5L) announced today that it has closed its previously announced bought deal private placement of 10,312,821 units of the Company (the “Units”), at a price of $2.10 per Unit, for aggregate gross proceeds to the Company of $21,656,924, including the issuance and sale of the Underwriters’ (as defined below) option (the “Offering”). Each Unit consists of one common share of the Company and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) until February 16, 2020 at an exercise price of $2.60 per Warrant Share, subject to adjustment in certain events. Net proceeds from the Offering will be used for exploration and development activities on the Company’s properties and for general corporate purposes.
The Offering was conducted by a syndicate of underwriters led by Canaccord Genuity Corp., as sole bookrunner and lead underwriter, and including GMP Securities L.P. (the “Underwriters”). In connection with completion of the Offering, the Underwriters received a cash commission of 7.0% and options to acquire a number of Units equal to 7.0% of the Units issued in the Offering until February 16, 2020 at an exercise price of $2.10. The Company paid a further cash commission of 3.0% and issued common shares equal to 3.0% of the Units issued in the Offering to a third-party who assisted in facilitating the Offering.
All securities issued or issuable under the Offering are subject to a statutory hold period lasting four months and one day following the closing of the Offering.
About Standard Lithium Ltd.
Standard Lithium’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The Company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The Company is also commencing resource evaluation on up to approximately 33,000 acres of brine leases located in the Smackover Formation.
Standard Lithium is listed on the TSX Venture under the trading symbol “SLL”; quoted on the OTCQX under the symbol “STLHF”; and on the Frankfurt Stock Exchange under the symbol “S5L”. Please visit the Company’s website at www.standardlithium.com.
For further information, contact Anthony Alvaro at (604) 240 4793.
On behalf of the Board,
Standard Lithium Ltd.
Robert Mintak, CEO & Director
The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain certain “Forward-Looking Statements” within the meaning of applicable Canadian securities laws. When used in this news release, the words “anticipate”, “believe”, “estimate”, “expect”, “target, “plan”, “forecast”, “may”, “schedule” and other similar words or expressions identify forward-looking statements or information. These forward-looking statements or information may relate to the anticipated use of proceeds of the Offering, future prices of commodities, accuracy of mineral or resource exploration activity, reserves or resources, regulatory or government requirements or approvals, the reliability of third party information, continued access to mineral properties or infrastructure, fluctuations in the market for lithium and its derivatives, changes in exploration costs and government regulation in Canada and the United States, and other factors or information. Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.
||02/18/2018 03:40:00 PM
||Farmers & Merchants Bancorp Reports Earnings for 2017
Farmers & Merchants Bancorp (OTCQX:FMCB) today announced that the Company earned net income of $28.4 million for the year-ending December 31, 2017, after giving effect to a one-time, non-cash $6.3 million re-measurement of the Company’s deferred tax asset (“DTA”) required under GAAP from the passage of the new Tax Cuts and Jobs Act. The non-recurring $6.3 million DTA re-measurement reduced net income for the year from what would have been $34.7 million on a non-GAAP basis to $28.4 million. Total assets at year-end were $3.1 billion, up 5.25% over the prior year.
GAAP net income of $28.4 million, after the impact of the DTA re-measurement, resulted in a return on average assets of 0.94% and a return on average equity of 9.66%. Non-GAAP adjusted net income of $34.7 million would have represented the highest level of earnings performance in the Company's history, up $5.0 million or 16.8% over the prior year, resulting in an adjusted return on average assets of 1.15% and an adjusted return on average equity of 11.79%. Refer to “Statement Regarding Use of Non-GAAP Financial Measures”.
On December 22, 2017, the Tax Cuts and Jobs Act was signed into law by the President. Among other things, this legislation reduces the corporate tax rate from 35% to 21% beginning January 1, 2018. U.S. generally accepted accounting principles require that all companies re-measure their deferred tax assets using the new lower corporate tax rate of 21% as of the date of enactment of the legislation. The Company believes that this reduction in the corporate tax rate will have a significant positive impact on our future financial performance, allowing us to earn-back the re-measurement in approximately one year. The majority of financial institutions in the country have also reported significant DTA re-measurements in the 4th quarter.
Kent Steinwert, Farmers & Merchants Bancorp’s Chairman, President and Chief Executive Officer, stated, “Excluding the non-recurring, non-cash re-measurement of our DTA in the fourth quarter, the adjusted net income for 2017 represented the highest level of earnings performance in the Company’s history. We continue to be pleased with the Company’s organic growth, which when combined with an improved yield on loans and leases allowed us to report solid operating profit growth for 2017, and a strong return on average assets and equity. In Management’s opinion, all of these metrics continue to compare favorably to other banks in our geographic region. Additionally, during 2017, our strategies of expanding into the San Francisco East Bay Area and entering the equipment leasing business continued to produce positive results that contributed to the successful year. As we look forward to 2018, we have a positive outlook given the growing economy, opportunities in our markets and the advantages created by reduced federal income tax rates.”
Loans and Credit Quality
In 2017, average total loans & leases grew $128.5 million, or 6.24% compared to the prior year. At year-end 2017 total loans and leases were $2.2 billion. This growth was broadly distributed over much of the Company’s portfolio segments, and was partially the result of: (1) the Company’s intensive business development efforts directed toward credit-qualified borrowers; (2) continued growth in the equipment leasing business; and (3) expansion of the Company’s service area into the San Francisco East Bay. As a result of rising short-term interest rates, the Company’s yield on loans and leases averaged 4.71% in 2017, compared to 4.47% in 2016.
Asset quality remained strong, with no non-accrual loans and leases at December 31, 2017, compared to $3.1 million at December 31, 2016. ORE decreased from $3.75 million at December 31, 2016 to $873,000 at December 31, 2017. The Company’s Texas Ratio was 0.25% at December 31, 2017, compared to 2.09% at December 31, 2016.
The provision for credit losses totaled $2.9 million in 2017 compared to $6.3 million in 2016. Net loan losses in 2017 exceeded loan recoveries by $427,000. As of December 31, 2017, the allowance for credit losses was $50.3 million or 2.27% of total loans and leases, up from $47.9 million, or 2.19% at the end of 2016.
During 2017, average total deposits grew $337.9 million or 14.6%. At year-end 2017 total deposits were $2.7 billion. At December 31, 2017, low-cost checking account balances totaled $1.43 billion or 52% of total deposits, and the average balances of these accounts grew 18.5% year-over-year, a rate that exceeded average total deposit growth.
Net interest income increased 13.9% to $108.3 million in 2017, due to a 14.61% increase in average total earning assets. Despite a continuing low (albeit rising) interest rate environment and fierce competitor pricing, the Company was able to achieve a net interest margin of 3.88% in 2017, down slightly from 3.89% in 2016. The Company was able to sustain this net interest margin in 2017 despite a significant increase in our net liquidity position (see Liquidity and Capital).
Non-interest income was $16.8 million in 2017, compared to $15.3 million in 2016, an increase of $1.5 million or 9.9%. During 2016 the Company recorded a $1.8 million Bargain Purchase Gain from the acquisition of Delta National Bank. Without this one-time gain, non-interest income would have increased $3.3 million, or 24.4% for the year ended 2017.
Non-interest expense was $67.8 million in 2017, compared to $58.2 million in 2016, an increase of $9.6 million or 16.5%. During 2016 the Company had a $5.9 million gain on sale of ORE which was recorded as a reduction to non-interest expense. Without this extraordinary gain, non-interest expense would have increased $3.7 million, or 5.8%, for the year ended 2017.
The Company’s efficiency ratio for 2017 was 54.2%, despite one-time acquisition costs associated with the Delta National Bancorp acquisition and significant investment in expanding the Company’s operations and modernizing our delivery technology.
Liquidity and Capital
In 2017, average cash, investment securities and interest bearing deposits with banks grew $221.5 million, or 47.8% compared to the prior year. At December 31, 2017, the Company’s cash, investment securities and interest bearing deposits with banks totaled $723.2 million. The Company did not have any borrowed funds at year-end.
At December 31, 2017, the Company’s total risk based capital ratio was 13.07%, an increase from 12.80% at December 31, 2016 and the total common equity tier 1 capital ratio was 11.43% up from 11.16% at the prior year-end, resulting in the highest possible regulatory classification of “Well Capitalized”. All of the Company’s capital is common equity with the exception of $10.3 million of subordinated debt (issued as Tier 1 qualifying trust preferred).
Statement Regarding Use of Non-GAAP Financial Measures
This press release presents the Company’s financial results in accordance with GAAP, but also contains certain non-GAAP financial measures related to the re-measurement of our DTA required from the passage of the new Tax Cuts and Jobs Act. Management believes the non-GAAP measures provide useful supplemental information to investors in analyzing the Company’s core operating results and comparing those results across reporting periods.
About Farmers & Merchants Bancorp
Farmers & Merchants Bancorp, traded on the OTCQX under the symbol FMCB, is the parent company of Farmers & Merchants Bank of Central California, also known as F&M Bank. Founded in 1916, F&M Bank is a locally owned and operated community bank, which proudly serves California through 28 convenient locations. In 2013, the Bank began an expansion into the San Francisco Bay Area with new full-service branches in Walnut Creek and Concord. In early 2018, a loan production office opened in Napa with a full-service branch in process. The Bank offers a full complement of loan, deposit, equipment leasing and treasury management products to businesses, as well as a full suite of consumer banking products. The FDIC awarded F&M Bank the highest possible rating of "Outstanding" in their CRA evaluation. For more information about Farmers & Merchants Bancorp and F&M Bank, visit fmbonline.com.
Statements concerning future performance, developments or events, expectations for growth and income forecasts, and any other guidance on future periods, constitute forward-looking statements that are subject to a number of risks and uncertainties. Actual results may differ materially from stated expectations. Specific factors include, but are not limited to, loan production, balance sheet management, levels of net interest margin, the ability to control costs and expenses, interest rate changes, the competitive environment, financial and regulatory policies of the United States government, water management issues in California and general economic conditions. Additional information on these and other factors that could affect financial results are included in our Securities and Exchange Commission filings. The Company disclaims any obligation to update any such factors or to publicly announce the results of any revisions to any forward-looking statements contained herein to reflect future events or developments.
Farmers & Merchants Bancorp
Stephen W. Haley, 209-367-2411
Executive Vice President and Chief Financial Officer
||02/18/2018 03:39:25 PM
||Arias Intel Issues Shareholder Update Letter
Arias Intel Corp. (OTC Markets: ASNT) (the "Company"), a technology, media and mobile gaming platform, today announced the issuance of a shareholder update letter from its Chairman and Chief Executive Officer, Kevin Gillespie.
Dear Fellow Shareholders,
We believe that the Company is successfully progressing on its business plan, as evidenced by our advancement on our commercialization strategy and technology milestones. In December 2017, we changed our corporate name from “First Harvest Corp.” to “Arias Intel Corp.” to better reflect both the evolution of the Company, as well as our vision for the future. The new name better articulates our plans to build a digital media platform for technology, media and gaming.
We believe we will begin to generate revenue from our mobile apps over the next few months, and we are excited for what is ahead in 2018. We look forward to sharing our progress with you. Below are our plans for our lines of business in 2018.
Ufly – On-demand delivery app development completed and is in beta testing on the Apple Developer platform. The Ufly platform is similar to an UberEATS-style delivery app model, providing on-demand legal medical cannabis to qualified patients and recreational users in states where cannabis has been legalized. The logistics-based app connects an authorized user to a selection of local, legal cannabis dispensaries in designated cities using their smartphone to select and place orders. The Company has developed the Ufly app for integration with blockchain technology and a cryptocurrency payment system. The Company believes leveraging blockchain technology may solve payment and security issues, especially for legal cannabis dispensaries. The decentralized ledger within the blockchain may allow for greater compliance and may solve banking issues surrounding the cannabis industry. The Company believes this will allow dispensaries to operate in a safer environment without handling cash while increasing business and overall customer satisfaction.
iNEO - Proprietary Cryptocurrency and Blockchain Technology Platform (“iNEO”). The Company plans to launch its iNEO ‘coin or token’ in 2018 as a medium of exchange which will be used to fund the purchase and sale of products or services from others within the same ecosystem. iNEO will initially be integrated with the Company’s portfolio of mobile games and apps. Additionally, iNEO will be developed with Application Programming Interfaces, or APIs, and open-source interfaces for other developers to utilize and create additional revenue opportunities for the Company.
Hemp Inc - mobile gaming app which recently ranked as the #1 Strategy Game on the iTunes App Store in multiple countries. We are nearing release of an updated version of the game and anticipate making additional announcements regarding celebrity game-endorsements, intellectual property development and an expanded mobile gaming portfolio.
SportXction - real-time, interactive software system which allows a user to make play-by-play wagers on a sporting event while the event is in progress. Wagering may be conducted online while viewing a live sporting event. SportXction accepts wagers not only on the outcome of the sporting event, but also on discrete parts of the event and on specific in-game situations for such sports as soccer, football, baseball, basketball, golf, tennis, rugby, cricket, among many others. The Company believes this may be applicable to its mobile games under development, but may also have a large European market for legalized gambling.
Balance Sheet - In regards to our capital structure and financing needs, we have invested heavily to accelerate our commercialization and growth plans. More recently, an institutional convertible note holder converted to equity, which has reduced our debt exposure. We are also in negotiations to further reduce additional debt on our balance sheet.
London Stock Exchange AIM Market (“AIM”) - To broaden our investor base, the Company intends to pursue a dual-listing, and has engaged a business development consultant in the United Kingdom for the proposed listing of the Company’s common stock on the Standard Segment of the Main Market of London Stock Exchange PLC, or the LSE.
Future Opportunities – In addition to the foregoing, we are also exploring opportunities to expand a suite of mobile games and apps that may or may not be cannabis related, but target similar audience demographics as our existing apps. We may explore these opportunities through the acquisition of operating companies, asset purchases or internal development.
We look forward to a successful 2018.
All the best,
Chairman and Chief Executive Officer
About Arias Intel Corp.
Arias Intel Corp. is a digital media platform for tech, media, and gaming, which includes mobile apps and gaming, augmented and virtual reality, on-demand delivery, digital and social media, and e-commerce. The Company plans to generate revenue through in-app purchases, service fees, and cross-channel advertising.
The Company's focus is on developing innovative technologies that leverage connectivity, distribution, and social networks. The Company intends to use its digital platforms to implement its unique marketing strategy that empowers viral and social mechanisms to reach a growing demographic that utilizes: (1) mobile apps and gaming, (2) social media, and (3) on-demand delivery. The Company believes its platforms are entertaining, convenient and scalable.
The Company intends to use its platform to build its subscriber base and boost users' engagement within its digital platforms to gather analytics and target advertising directly to users based on their preferences. The Company is also exploring opportunities to expand a suite of mobile games and apps that target similar audience demographics. The Company may explore these opportunities through the acquisition of operating companies, asset purchases or internal development.
For more information, please visit: www.AriasIntel.com
This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of the words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “may,” “continue,” “predict,” “potential,” “project” and similar expressions that are intended to identify forward-looking statements. All forward-looking statements speak only as of the date of this press release. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, objectives, expectations and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give no assurance that these plans, objectives, expectations or intentions will be achieved. Forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and assumptions that could cause actual results to differ materially from historical experience and present expectations or projections. Actual results to differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly. Forward-looking statements also are affected by the risk factors described in the Company’s filings with the U.S. Securities and Exchange Commission. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
Arias Intel Corp.
||02/18/2018 03:38:30 PM
||CannaRoyalty Congratulates National Access Cannabis Corp. on the Conditional Approval of a License to Operate Private Retail Cannabis Stores in Manitoba
– CannaRoyalty Corp. (CSE: CRZ) (OTCQX: CNNRF) (“CannaRoyalty”
or the “Company”), an active investor and operator in the legal cannabis industry, announced today that
National Access Cannabis Corp. (“NAC”) has been chosen by the government of Manitoba as one of four
conditional recipients of licenses to operate privately owned retail cannabis stores in Manitoba.
CannaRoyalty has a binding term sheet with NAC regarding the distribution of cannabis products for
Manitoba dispensaries. CannaRoyalty, Cannabis Wheaton Income Corp. and Tilray collectively
participated in NAC’s response to Manitoba’s November 2017 Request for Proposals (“RFP”). The number
of retail locations to be opened by NAC remains subject to ongoing discussion with the Province.
“We would like to congratulate NAC on this substantial win and appreciate CannaRoyalty’s inclusion as
part of this RFP,” said Marc Lustig, CEO of CannaRoyalty. “This development reinforces the quality of
CannaRoyalty’s value-added downstream cannabis product portfolio, which has received growing
attention from Canadian and international players over the past several months. This partnership will
provide NAC access to key elements of CannaRoyalty’s product suite, which have been proven in mature,
sophisticated markets such as California. As Health Canada finalizes its proposed approach to the
regulation of cannabis and moves to allow the production and sale of an extended product shelf such as
edibles, pre-rolls and concentrates, we anticipate significant demand from consumers in these areas as
we have seen in other mature cannabis markets, globally.”
“With a proven portfolio of branded products and years of industry expertise, we are pleased to work
with CannaRoyalty to provide Manitobans a greater variety of choice in our new retail stores,” said Mark
Goliger, CEO of NAC. “CannaRoyalty’s deep retail cannabis, distribution and product experience combined
with our history of running safe and responsible medical care clinics contributed to our successful
CannaRoyalty is an active investor and operator in the legal cannabis industry. Our focus is building and
supporting a diversified portfolio of growth-ready assets in high-value segments of the cannabis sector,
including research, consumer brands, devices and intellectual property. Our management team combines
a hands-on understanding of the cannabis industry with seasoned financial know-how, assembling a
platform of holdings via royalty agreements, equity interests, secured convertible debt, licensing
agreements and its own branded portfolio. CannaRoyalty’s shares trade on the Canadian Stock Exchange
(CSE) under the symbol CRZ and internationally on the OTCQX under the symbol CNNRF.
For further inquiries, please contact:
Jonathan Ross, CFA
LodeRock Advisors Inc.
Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and
uncertainties concerning the specific factors disclosed here and elsewhere in CannaRoyalty's periodic
filings with Canadian securities regulators. When used in this news release, words such as "will, could,
plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forwardlooking
Forward-looking statements may include, without limitation, statements regarding the Company’s
expectations with respect to pursuing new opportunities and future growth for Trichome and other
statements of fact.
Although CannaRoyalty has attempted to identify important factors that could cause actual results,
performance or achievements to differ materially from those contained in the forward-looking statements,
there can be other factors that cause results, performance or achievements not to be as anticipated,
estimated or intended, including, but not limited to: competition from banks and other lenders; movements
and long term trends in interest rates; the ability of management to select companies that will increase in
value and to compete for desirable transactions; the ability to source desirable transactions; dependence
on obtaining regulatory approvals; investing in target companies or projects which have limited or no
operating history; changes in laws; limited operating history; reliance on management; requirements for
additional financing; and regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management's
expectations or estimates of future developments, circumstances or results will materialize. As a result of
these risks and uncertainties, the results or events predicted in these forward-looking statements may differ
materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking
statements in this news release are made as of the date of this release. CannaRoyalty disclaims any intention
or obligation to update or revise such information, except as required by applicable law, and CannaRoyalty
does not assume any liability for disclosure relating to any other company mentioned herein
||02/18/2018 03:37:41 PM
||TGI Update On evTransportation Services, Inc. Joint Venture
Ewing, NJ, February 16, 2018 -- TGI SOLAR POWER GROUP
INC. (OTC Markets: TSPG) (“TGI”), a diversified technology
company, would like to take this opportunity to provide a Corporate
update to its shareholders and interested parties. Since signing MOU
with evTransportation Services, Inc. (“evTS”), exclusive worldwide
distributor of FireFly ESV ® Essential Service Vehicles, the
Company is aggressively pursuing its objectives of becoming a
major supplier of ESV to the rapidly expanding electric vehicles
industry, which is expected to see increases in demand over the next
few years, according to research. TGI management representatives
are currently meeting with European auto manufacturers, based on
earlier established relationships and arrangements, in efforts to
negotiate the terms and to start production of ESVs.
The Parties earlier agreed that evTS will be responsible for
engineering and new European vehicle designs, while TGI will be
responsible for business development, sales, marketing, financing
and dealing with the local manufacturing requirements and
workforce. The initial hub for the Joint Venture operation in Europe
will be established in Kiev.
About ev Transportation Services, Inc, (http://evtaas.com). evTS’
mission is to become the premier company in the fleet management
solutions business through the design and development of energy
efficient all-electric utility vehicles for the “Essential Services”
transportation market, providing tightly integrated vehicle
For more information please see www.otcMarkets.com under ticker
symbol "TSPG", and visit our Facebook page https://
About TGI Solar: TGI SOLAR POWER GROUP INC. is a
diversified holding company. TGI's strategy is to acquire innovative
and patented technologies, components, processes, designs and
methods with commercial value that will give competitive market
advantage and generate shareholder value.
Safe Harbor Statements under the Private Securities Litigation
Reform Act of 1965: Those statements contained herein which are
not historical are forward-looking statements, and as such, are
subject to risks and uncertainties that could cause actual operating
results to materially differ from those contained in the forwardlooking
statements. Such statements include, but are not limited to,
certain delays that are beyond the company's control, with respect to
market acceptance of new technologies, or product delays in the
evaluation of products, and other risks, as detailed in the company's
periodic filings with the Securities and Exchange Commission
* FireFly ESV ® is a licensed registered trademark of ev
Transportation Services, Inc.
For further info:
||02/18/2018 03:36:29 PM
||Hollywall Entertainment, Inc., (HWAL) Announces 2018 Updates
Hollywall Entertainment, Inc., (OTC: HWAL), announces Financial Industry Regulatory Agency (FINRA) has approved HWAL’s application of its three-tier Warrant Program record date of March 27, 2018.
HWAL revised the original record date of December 26, 2017 to March 27, 2018 to give adequate notice to its shareholders and the investment community of the three-tier warrant program. All information regarding the warrant program can also be found at the company’s website, https://hollywall.com/
The warrants purchased by Shareholders of record date of March 27, 2018 shall be structured as follows:
• The first Warrant, (A Warrant), is exercisable for 30 days to holders of common stock of HWAL as of the record date March 27, 2018. The A warrant provides shareholders the right to purchase from the company directly three (3) additional shares of restricted common stock for every share they own as of the date of March 27, 2018 at a price of $0.85 per share. Shareholders can buy A Warrants from March 30, 2018 until April 29, 2018.
• Upon expiration of the A warrant, the A warrant becomes a B warrant which is exercisable for 60 days after the expiration of the A warrants. The B warrant provides for the right to buy 1 share of restricted common stock at a price of $2.00. Shareholders can buy B Warrants from April 30, 2018 until June 29, 2018.
• Upon expiration of the B warrant, the B warrant becomes the C warrant which is exercisable for 90 days after the expiration of the B warrants. The C warrant provides for the right to buy 1 share of restricted common stock at a price of $5.00. Shareholders can buy C Warrants from June 30, 2018 until September 28, 2018.
Along with the multi-tiered warrants, the Company has created several new Preferred series of equity securities.
HWAL is considering a year end tender offer for all its currently issued and outstanding common stock. HWAL continues to work with the investment banking community and plans to release further detail regarding the structure and timing of the tender offer for all common shares and other anticipated benefits for all its shareholders.
HWAL has engaged one of the nation’s top auditing firms with intention to become fully reporting for future up-listing.
In January 2017, the company engaged Action Stock Agent Transfer www.actionstocktransfer.com, as their stock transfer agent replacing Cleartrust LLC. Action Stock Transfer’s knowledgeable staff has been involved in the securities industry for over twenty years and prides itself in providing full service stock transfer, custodial record keeping, and Edgar and other compliance and services efficiently.
HWAL is establishing its newest corporate executive offices in both New York and Washington DC.
Hollywall Music has released the “Soul of America – Celebration” music collector series featuring performances by recording legends: Ray Charles, James Brown, B. B. King, Barry White, Percy Sledge, Betty Everette, Count Basie, John Lee Hooker, Chuck Berry, Lena Horne, Etta James, Fats Domino, Sam and Dave, and Little Richard.
Soul of America is a planned two-hour live event television production originally scheduled to be taped from the National Museum of African American History and Culture during the recent 58th Presidential Inauguration rescheduled for Production and future network broadcast in June 2018.
Soul of America will celebrate and highlight the historic accomplishments of some of the world’s greatest sports, entertainment, business and political Legends of our time, “told thru the historic Lens of the Museum” with star- studded stage performances in dance, music and spoken word tributes, as well as recognize the tremendous growth of some of our nation’s great American cities, as told by the voices of America’s Mayors thru live and video presentations.
The company has engaged Scalar Analytics, https://www.scalaranalytics.com/ to prepare a current Valuation report. Scalar will employ traditional valuation methods in determining an enterprise range of values including market, income, and cost valuation approaches. They will analyze the most current valuations of publicly comparable companies, valuation of comparable private acquisition and investment transactions, and the discounted cash flow valuation approach. Scalar is a full-service business valuation firm with a full range of services for tax, financial reporting, transaction advisory, and litigation purposes. Scalar is a leader in the valuation industry and have performed more than 3,000 independent valuation engagements for over 1,400 public and private companies across a wide range of industries including software, hardware, internet, mobile, medical device, retail and media.
Hollywall continues its global search in expanding its executive management team, board of Directors and Advisory Boards.
About Hollywall Entertainment Inc.
Hollywall Entertainment, Inc., www.hollywall.com, is a multifaceted media and entertainment company engaged in maximizing rights to its music, film, television, home videos and software game libraries. The company is developing a digital distribution and verification system to improve customer delivery, quality control and revenues for artists, writers, content developers, copyright owners and shareholders. Hollywall owns exclusive and non-exclusive rights to market, manufacture and distribute over 17,500 songs from Music Recording Masters. Hollywall's recorded music master rights consist of all the “Proprietary Rights,” as outlined in its original contracts on file. The master recordings contain performances by such legends as Ray Charles, Ella Fitzgerald, The Jackson 5, Frank Sinatra, Dolly Parton, Elvis Presley, Tony Bennett, The Bee Gees, Chicago, Platters, George Gershwin, Marvin Gaye, James Brown, The Who, Janis Joplin, Rolling Stones, Nat King Cole, John Lee Hooker, Willie Nelson, Rod Stewart, Hall and Oates, James Taylor, Etta James, Aretha Franklin and other multiple platinum selling acts. The music master recordings include songs that have never been released in addition to songs that have been released by other record companies which hold similar licensing rights to market the songs.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward- looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements because of a wide range of factors.
Hollywall Entertainment, Inc.
||02/18/2018 03:35:21 PM
||OncBioMune Provides Update on Market Activity
OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary immunotherapy cancer vaccine technology and targeted cancer therapies, wishes to make the following statements regarding recent market activity in its common stock traded on the OTCQB marketplace.
On February 12, 2018, the Company was informed by OTC Markets about certain promotional activity in relation to OBMP common stock, including newsletter emails. From time to time, the Company engages investor relations services to provide advertising and communication services for news and corporate information. Since January 1, 2017, the Company has engaged RCI, American Capital Ventures, Inc. and Viper Enterprises LLC. All communications are to remain within parameters of public information and corporate facts. Neither the Company, its officers, directors or to its knowledge any shareholders participate in material creation or have any control in its content or dissemination. Until being notified by OTC Markets, the Company was unaware of the identified promotional activity and remains unaware of the full nature of any promotional activity or the extent of its dissemination. The Company, to its knowledge, has not compensated the creators of the identified promotional activity. None of the statements regarding the fundamentals of the Company brought to the attention of the Company were materially false or misleading. Since being informed by OTC Markets, the Company has not engaged any additional investor relations, advertising and communications services and has no current intentions of doing so going forward.
The Company attributes any increase in trading volumes to news of a letter of intent with an esteemed urology clinic in Texas, disbanding of the joint venture in Mexico as filed with the Securities and Exchange Commission to focus on domestic development of ProscaVax for prostate cancer and developments with a major Northeastern U.S. university for a Phase 2 trial of ProscaVax for early-stage prostate cancer. The Company has also increased the number of issued and outstanding common stock over the past few months due to the conversions of convertible notes, as discussed below, which can contribute to increased volume levels.
Neither of the company's executive officers or directors, nor, to the knowledge of the company, any controlling shareholders sold or purchased shares of common stock of the company within the past 90 days (or anytime in recent years for that matter). Leadership remains steadfast in commitment to develop shareholder value through pipeline development.
In order to fund ProscaVax development and general corporate expenses, the Company previously issued convertible debentures, as disclosed with details readily available through regular filings with the Securities and Exchange Commission in current reports filed on January 30, 2018, July 26, 2017, June 6, 2017 and November 28, 2016. In recent months, these convertible instruments have been being converted into equity securities at prices discounted to the market price of OBMP stock at the time of issuance, per the issued securities’ terms.
The Company is committed to compliance with the OTC Markets Group policy on stock promotion and the OTCQB standards. The Company encourages those interested in the Company to rely solely on information included in press releases issued and distributed by the Company through approved news wire or disclosure and news services, combined with its filings and disclosures made with the Securities and Exchange Commission, as well as information provided through the OTC Markets and OncBioMune websites.
About OncBioMune Pharmaceuticals, Inc.
OncBioMune Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, based on their proprietary vaccine technology designed to stimulate the immune system to attack tumor cells without damaging healthy tissue. Our lead pipeline product, ProscaVax™, has successfully completed enrollment and vaccination of the prostate cancer patients and is collecting long-term follow-up results for the 1a portion of their Phase 1a/1b clinical trial. Due to the impressive results and proven safety profile of ProscaVax™, OncBioMune is forgoing the 1b portion of the trial to advance ProscaVax™ into Phase 2 studies. A Phase 2 trial is scheduled to commence at a major Northeast U.S. university cancer research hospital evaluating ProscaVax as a front-line therapy in prostate cancer patients in the “active surveillance” category, representing the first mid-stage trial of an immunotherapeutic vaccine in this patient population. OncBioMune also has a portfolio of targeted therapies, some of which are biosimilars and generics to blockbuster drugs. OncBioMune is headquartered in Baton Rouge, LA.
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that could cause OncBioMune Pharmaceuticals' actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. OncBioMune Pharmaceuticals has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Among other factors that could cause actual results to differ materially from those expressed in forward-looking statements are OncBioMune Pharmaceuticals' need for, and the availability of, substantial capital in the future to fund its operations and research and development; the fact that OncBioMune Pharmaceutical's vaccines and therapeutics may not successfully complete pre-clinical or clinical testing, or be granted regulatory approval to be sold and marketed in the United States or elsewhere. A more complete description of these risk factors is included in OncBioMune Pharmaceutical's filings with the Securities and Exchange Commission. You should not place undue reliance on any forward-looking statements. OncBioMune Pharmaceuticals undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
OncBioMune Pharmaceuticals, Inc.
President and Chief Financial Officer
||02/18/2018 03:34:39 PM
||RAADR working in local schools to help protect teachers and students from school violence
RAADR, Inc. (OTC PINK: RDAR), a technology and software development company that monitors cyber-bullying on social media platforms through its proprietary, artificial intelligence-based application, announced Friday Feb 16th they are now actively and aggressively licensing the BullyRaadr platform in local schools and communities in the Phoenix area.
BullyRAADR is an app exclusively for students to report bullying at school. Students can report incidents of bullying and document their encounters with photographs, videos, text, and social media. The mission of BullyRAADR is to make our schools a No Bully Zone. Thanks to partnerships with people like Kenny Dobbs and Gary Smith, along with companies like DAVE & BUSTERS, we are working to continue to fight bullying in a meaningful way.
BullyRAADR allows administrators to take action where needed and better track incidents of bullying on their campus. The anonymity of the app protects students and allows them to feel safe reporting incidents of bullying. Student safety is a core value of the BullyRAADR platform.
As new details surface regarding the recent shooting in Florida, we've learned the shooter wrote about his plans on YouTube prior to the event taking place. While the FBI & YouTube were notified, these entities are overwhelmed by such reports on a daily basis and without a "boots on the ground" perspective, have no way to accurately assess such imminent threats as effectively as members of the community can. RAADR and BullyRAADR allows for open communication between students, parents, administrators and law enforcement which we believe is key to increasing the likelihood of prevention.
Here is a quote from Mrs. Minette Klenner a Social Studies teacher at Arizona Charter Academy. Her school has been able to use the BullyRAADR platform successfully and intervene in a possible altercation between students after school hours and her opinion on how the app could help prevent such incidents like the recent shooting in Florida:
"The BullyRAADR platform is a huge benefit to us as a school. We were able to already deal with incidents of bullying as well as a published possible altercation between students after school hours posted on social media.
Today we are wearing heavy hearts as we reflect on the shooting in Florida and we have observed that there were signs that this was a troubled young man and if they had RAADR and or BullyRAADR possibly they could have provided help for him prior to this incident. It only works if the students know that they can post anonymously and not have repercussions for posting, but once students understand that this is forum where they can turn to adults for help they will take action as I have stated above to make sure that all students are safe and protected."
It is our aim to continue to provide the ability to detect and react, in advance, before anyone gets hurt and clearly our members echo our mission in their words and feedback:
"My goal is to have the BullyRAADR platform in every School in America. It works! Its already helping schools here in Phoenix and it's our goal to help PREVENT these cases of school shootings from happening! The students using our platform are truly using it and reporting things that are preventing things at this very moment! Huge win for all of us!" said CEO Jacob DiMartino
CONTACT: Jacob Dimartino, email@example.com, (480) 755-0591
||02/18/2018 03:33:55 PM
||Cardax Inks Deal to Distribute ZanthoSyn® in China
Cardax, Inc. (OTCQB: CDXI) announced today that it has signed a Purchase Agreement (the "Agreement") with Health Elite Club Limited ("HECL") of Hong Kong for distribution of ZanthoSyn®, the Company's premium astaxanthin dietary supplement for inflammatory health and longevity, in China, Hong Kong, Macau, and Taiwan (the "Territories").
HECL is a Hong Kong based company founded by a group of entrepreneurs who are strong proponents of healthy aging. It is a membership-based, invitation-only club targeting high net worth / high-profile Chinese from the greater China area as the foundation for building large-scale consumer awareness. As is the custom in China, most sales will occur through an online platform.
ZanthoSyn® will be distributed in the Territories under HECL's house brand, Puerfons, with all packaging and marketing materials to feature the ZanthoSyn® brand. HECL is responsible for all regulatory approvals in the Territories and the Agreement is governed by the laws of New York.
"We are very pleased to be working with such a highly entrepreneurial company as HECL," said David G. Watumull, Cardax President and CEO. "HECL's distribution model looks quite promising and their principals are highly credible. We look forward to building our relationship as HECL's business grows in China."
"U.S. products with scientific and manufacturing credibility such as ZanthoSyn® are highly prized in China," said Li Wu, Chairman of HECL," and we are excited to bring Puerfons ZanthoSyn® into this important market. "With China's increasing industrialization and associated pollution challenges, inflammatory health, with its relationship to longevity, is increasingly important, especially to its rapidly growing aging population."
The agreement with HECL reflects Cardax's mission to develop and commercialize the safest, most effective anti-inflammatory products for health and longevity. Cardax is also developing and commercializing CDX-085, its next generation patented ZanthoSyn® product for more concentrated astaxanthin product applications. CDX-085 was chosen by the National Institutes of Health as a top anti-aging prospect.
"This expansion into China is another key building block of our goal to become the inflammatory health, anti-aging leader," added George W. Bickerstaff, Cardax Chairman.
Separately, Cardax announced that ZanthoSyn® is also available in GNC stores in Guam, where the Company will utilize the successful physician education and GNC outreach programs used in Hawaii to grow awareness in the local community and among Guam's many Asian visitors.
Cardax devotes substantially all of its efforts to developing and commercializing dietary supplements. Cardax is initially focusing on astaxanthin, which is a powerful and safe naturally occurring anti-inflammatory that supports health and longevity.* The safety and efficacy of Cardax's products have not been directly evaluated in clinical trials or confirmed by the FDA.
About Health Elite Club
Health Elite Club is a Hong Kong based company founded by a group of entrepreneurs who are strong proponents of healthy aging. The mission of HECL is to bring cutting edge products and services to its valued clients. HECL also promotes healthy lifestyles and creates customized solutions based on individual health conditions. HECL is a membership-based, invitation-only club targeting high net worth / high-profile Chinese from the greater China area.
ZanthoSyn® is a physician recommended anti-inflammatory supplement for health and longevity that features astaxanthin with optimal absorption and purity.* ZanthoSyn® is sold online and in GNC stores. ZanthoSyn® contains astaxanthin, which is Generally Recognized as Safe (GRAS) according to FDA regulations.
Astaxanthin is a clinically studied compound with safe anti-inflammatory activity that supports joint health, cardiovascular health, metabolic health, liver health, and longevity.*
Media and Investors
This release may contain certain forward-looking statements regarding our prospective performance and strategies within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of said safe harbor provisions. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations of our company, are generally identified by use of words "anticipate," "believe," "estimate," "expect," "intend," "plan," "project," "seek," "strive," "try," or future or conditional verbs such as "could," "may," "should," "will," "would," or similar expressions. Our ability to predict results or the actual effects of our plans or strategies is inherently uncertain. Accordingly, actual results may differ materially from anticipated results. Some of the factors that could cause our actual results to differ from our expectations or beliefs include, without limitation, the risks discussed from time to time in our filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Except as required by applicable law or regulation, we undertake no obligation to update these forward-looking statements to reflect events or circumstances that occur after the date on which such statements were made.
||02/18/2018 03:32:24 PM
||MomentumHunters Watchlist - $SDVI $WRFX $BIEL $AHGIF $PDXP $VICT $CHIT $UHLN
||01/19/2018 01:11:56 AM